Mycobacteria release active membrane vesicles that modulate immune responses in a TLR2-dependent manner in mice

Journal of Clinical Investigation

Volumn 121, Issue 4, 2011, Pages 1471-1483

  Prados Rosales, Rafael ^a   Baena, Andres ^a   Martinez, Luis R ^a,e   Luque Garcia, Jose ^b   Kalscheuer, Rainer ^c   Veeraraghavan, Usha ^d   Camara, Carmen ^b   Nosanchuk, Joshua D ^a   Besra, Gurdyal S ^d   Chen, Bing ^a   Jimenez, Juan ^a   Glatman Freedman, Aharona ^a   Jacobs Jr , William R ^a   Porcelli, Steven A ^a   Casadevall, Arturo ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^e LONG ISLAND UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; FEMALE; HISTOPATHOLOGY; IMMUNE RESPONSE; LUNG INFECTION; MACROPHAGE; MEMBRANE VESICLE; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEOMICS;

ANIMALS; BACTERIAL PROTEINS; FEMALE; LIPOPROTEINS; LUNG; MACROPHAGES; MEMBRANES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, ELECTRON, TRANSMISSION; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; PROTEOMICS; TOLL-LIKE RECEPTOR 2; TUBERCULOSIS, PULMONARY; VIRULENCE;

EID: 79953304475     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI44261     Document Type: Article

References (50)

1. Kuehn MJ, Kesty NC. Bacterial outer membrane vesicles and the host-pathogen interaction. Genes Dev. 2005;19(22):2645-2655. (Pubitemid 41627932)
2. Deatherage BL, Lara JC, Bergsbaken T, Rassoulian Barrett SL, Lara S, Cookson BT. Biogenesis of bacterial membrane vesicles. Mol Microbiol. 2009;72(6):1395-1407.
3. Beveridge TJ. Structures of gram-negative cell walls and their derived membrane vesicles. J Bacteriol. 1999;181(16):4725-4733. (Pubitemid 29383496)
4. Rivera J, Cordero RJ, Nakouzi AS, Frases S, Nicola A, Casadevall A. Bacillus anthracis produces membrane-derived vesicles containing biologically active toxins. Proc Natl Acad Sci U S A. 2010;107(44):19002-19007.
5. Rodrigues ML, et al. Extracellular vesicles produced by Cryptococcus neoformans contain protein components associated with virulence. Eukaryot Cell. 2008;7(1):58-67. (Pubitemid 351959594)
6. Marsollier L, et al. Impact of Mycobacterium ulcerans biofilm on transmissibility to ecological niches and Buruli ulcer pathogenesis. PLoS Pathog. 2007;3(5):e62.
7. Bloom BR, Fine PEM. The BCG experience: Implications for future vaccines against tuberculosis. In: Bloom BR, ed. Tuberculosis, Pathogenesis, Protection and Control. Washington, DC, USA: American Society for Microbiology Press; 1994:531-557.
8. Davis JM, Ramakrishnan L. The role of the granuloma in expansion and dissemination of early tuberculous infection. Cell. 2009;136(1):37-49.
9. Feldmesser M, Casadevall A. Effect of serum IgG1 to Cryptococcus neoformans glucuronoxylomannan on murine pulmonary infection. J Immunol. 1997;158(2):790-799. (Pubitemid 127492656)
10. Jo EK, Yang CS, Choi CH, Harding CV. Intracellular signalling cascades regulating innate immune responses to Mycobacteria: branching out from Toll-like receptors. Cell Microbiol. 2007;9(5):1087-1098. (Pubitemid 46547129)
11. Brightbill HD, et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science. 1999;285(5428):732-736.
12. Pecora ND, Gehring AJ, Canaday DH, Boom WH, Harding CV. Mycobacterium tuberculosis LprA is a lipoprotein agonist of TLR2 that regulates innate immunity and APC function. J Immunol. 2006;177(1):422-429. (Pubitemid 43939154)
13. Gehring AJ, Dobos KM, Belisle JT, Harding CV, Boom WH. Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing. J Immunol. 2004;173(4):2660-2668. (Pubitemid 39063126)
14. Gilleron M, Ronet C, Mempel M, Monsarrat B, Gachelin G, Puzo G. Acylation state of the phosphatidylinositol mannosides from Mycobacterium bovis bacillus Calmette Guerin and ability to induce granuloma and recruit natural killer T cells. J Biol Chem. 2001;276(37):34896-34904.
15. Means TK, Wang S, Lien E, Yoshimura A, Golenbock DT, Fenton MJ. Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol. 1999;163(7):3920-3927. (Pubitemid 29450920)
16. Beatty WL, Rhoades ER, Ullrich HJ, Chatterjee D, Heuser JE, Russell DG. Trafficking and release of mycobacterial lipids from infected macrophages. Traffic. 2000;1(3):235-247.
17. Bauman SJ, Kuehn MJ. Purification of outer membrane vesicles from Pseudomonas aeruginosa and their activation of an IL-8 response. Microbes Infect. 2006;8(9-10):2400-2408. (Pubitemid 44499035)
18. McBroom AJ, Kuehn MJ. Release of outer membrane vesicles by Gram-negative bacteria is a novel envelope stress response. Mol Microbiol. 2007;63(2):545-558. (Pubitemid 46058939)
19. Kremer L, et al. Identification and structural characterization of an unusual mycobacterial monomeromycolyl-diacylglycerol. Mol Microbiol. 2005;57(4):1113-1126. (Pubitemid 41139870)
20. Rezwan M, Grau T, Tschumi A, Sander P. Lipoprotein synthesis in mycobacteria. Microbiology. 2007;153(pt 3):652-658. (Pubitemid 46444362)
21. Fahey TJ 3rd, et al. Macrophage inflammatory protein 1 modulates macrophage function. J Immunol. 1992;148(9):2764-2769.
22. Bansal K, Kapoor N, Narayana Y, Puzo G, Gilleron M, Balaji KN. PIM2 Induced COX-2 and MMP-9 expression in macrophages requires PI3K and Notch1 signaling. PLoS One. 2009;4(3):e4911.
23. Giri PK, Schorey JS. Exosomes derived from M. Bovis BCG infected macrophages activate antigen-specific CD4+ and CD8+ T cells in vitro and in vivo. PLoS One. 2008;3(6):e2461.
24. Besra GS, Morehouse CB, Rittner CM, Waechter CJ, Brennan PJ. Biosynthesis of mycobacterial lipoarabinomannan. J Biol Chem. 1997;272(29):18460-18466. (Pubitemid 27306441)
25. Schlesinger LS, Hull SR, Kaufman TM. Binding of the terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages. J Immunol. 1994;152(8):4070-4079. (Pubitemid 24111079)
26. Nigou J, Zelle-Rieser C, Gilleron M, Thurnher M, Puzo G. Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cells: evidence for a negative signal delivered through the mannose receptor. J Immunol. 2001;166(12):7477-7485. (Pubitemid 32525626)
27. Fratti RA, Backer JM, Gruenberg J, Corvera S, Deretic V. Role of phosphatidylinositol 3-kinase and Rab5 effectors in phagosomal biogenesis and mycobacterial phagosome maturation arrest. J Cell Biol. 2001;154(3):631-644. (Pubitemid 34286167)
28. Vergne I, Chua J, Deretic V. Tuberculosis toxin blocking phagosome maturation inhibits a novel Ca2+/calmodulin-PI3K hVPS34 cascade. J Exp Med. 2003;198(4):653-659. (Pubitemid 37040399)
29. Dao DN, et al. Mycobacterium tuberculosis lipomannan induces apoptosis and interleukin-12 production in macrophages. Infect Immun. 2004;72(4):2067- 2074. (Pubitemid 38419919)
30. Guidry TV, Hunter RL Jr, Actor JK. Mycobacterial glycolipid trehalose 6,6'-dimycolate-induced hypersensitive granulomas: contribution of CD4+ lymphocytes. Microbiology. 2007;153(pt 10):3360-3369. (Pubitemid 47629541)
31. Rhoades ER, Geisel RE, Butcher BA, McDonough S, Russell DG. Cell wall lipids from Mycobacterium bovis BCG are inflammatory when inoculated within a gel matrix: characterization of a new model of the granulomatous response to mycobacterial components. Tuberculosis (Edinb). 2005;85(3):159-176. (Pubitemid 40585805)
32. Chen M, et al. Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death. J Exp Med. 2008;205(12):2791-2801.
33. Taylor JL, et al. Role for matrix metalloproteinase 9 in granuloma formation during pulmonary Mycobacterium tuberculosis infection. Infect Immun. 2006;74(11):6135-6144. (Pubitemid 44657392)
34. Volkman HE, Pozos TC, Zheng J, Davis JM, Rawls JF, Ramakrishnan L. Tuberculous granuloma induction via interaction of a bacterial secreted protein with host epithelium. Science. 2010;327(5964):466-469.
35. Abel B, et al. Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. J Immunol. 2002;169(6):3155-3162. (Pubitemid 35013161)
36. Bafica A, Scanga CA, Feng CG, Leifer C, Cheever A, Sher A. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. J Exp Med. 2005;202(12):1715-1724. (Pubitemid 41815877)
37. Sugawara I, Yamada H, Li C, Mizuno S, Takeuchi O, Akira S. Mycobacterial infection in TLR2 and TLR6 knockout mice. Microbiol Immunol. 2003;47(5):327-336. (Pubitemid 36604618)
38. Mayer-Barber KD, et al. Caspase-1 independent IL-1beta production is critical for host resistance to mycobacterium tuberculosis and does not require TLR signaling in vivo. J Immunol. 2010;184(7):3326-3330.
39. Chensue SW, Warmington K, Ruth J, Lincoln P, Kuo MC, Kunkel SL. Cytokine responses during mycobacterial and schistosomal antigen-induced pulmonary granuloma formation. Production of Th1 and Th2 cytokines and relative contribution of tumor necrosis factor. Am J Pathol. 1994;145(5):1105-1113. (Pubitemid 24345658)
40. Chensue SW, Warmington KS, Ruth JH, Lincoln P, Kunkel SL. Cytokine function during mycobacterial and schistosomal antigen-induced pulmonary granuloma formation. Local and regional participation of IFN-gamma, IL-10, and TNF. J Immunol. 1995;154(11):5969-5976.
41. Gordon S. Alternative activation of macrophages. Nat Rev Immunol. 2003;3(1):23-35. (Pubitemid 37328697)
42. Lyadova IV, et al. In mice, tuberculosis progression is associated with intensive inflammatory response and the accumulation of gr-1 cells in the lungs. PLoS One. 2010;5(5):e10469.
43. Antonelli LR, et al. Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population. J Clin Invest. 2010;120(5):1674-1682.
44. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol. 2009;9(3):162-174.
45. Harding CV, Boom WH. Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors. Nat Rev Microbiol. 2010;8(4):296-307.
46. Schwebach JR, et al. Glucan is a component of the Mycobacterium tuberculosis surface that is expressed in vitro and in vivo. Infect Immun. 2002;70(5):2566-2575. (Pubitemid 34408401)
47. Besra GS. Preparation of cell-wall fractions from mycobacteria. Methods Mol Biol. 1998;101:91-107.
48. Laval F, Laneelle MA, Deon C, Monsarrat B, Daffe M. Accurate molecular mass determination of mycolic acids by MALDI-TOF mass spectrometry. Anal Chem. 2001;73(18):4537-4544. (Pubitemid 32868257)
49. Takeuchi O, et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity. 1999;11(4):443-451. (Pubitemid 29504199)
50. Roberts AD, Belisle JT, Turner J, Gonzalez-Juarrero M, Cooper AM, Orme IM. Murine models of tuberculosis. In: Kaufmann SHE, Kabelitz D, eds. Methods in Microbiology. Vol. 32. Burlington, Massachusetts, USA: Academic Press Ltd; 2002:433-462.